DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Nicolas JM, Hannestad J, Holden D. et al.
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
Epilepsia 2016;
57: 201-209
We do not assume any responsibility for the contents of the web pages of other providers.